Flow Traders U.S.’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Flow Traders U.S.’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Buy	+12,693	New	+$381K	0.02%	678
2026 Q1	–	Sell	-41,395	Closed	-$1.08M	–	1141
2025 Q4	$1.08M	Buy	41,395 +13,679	+49%	+$352K	0.04%	377
2025 Q3	$655K	Sell	27,716 -17,688	-39%	-$391K	0.03%	529
2025 Q2	$931K	Buy	+45,404	New	+$914K	0.03%	434
2025 Q1	–	Sell	-94,333	Closed	-$2.13M	–	1108
2024 Q4	$2.13M	Buy	+94,333	New	+$2.26M	0.09%	200
2022 Q4	–	Sell	-11,470	Closed	-$303K	–	989
2022 Q3	$303K	Buy	+11,470	New	+$354K	0.02%	627
2022 Q2	–	Sell	-43,315	Closed	-$1.49M	–	911
2022 Q1	$1.49M	Buy	+43,315	New	+$1.53M	0.05%	297
2021 Q4	–	Sell	-19,542	Closed	-$991K	–	912
2021 Q3	$991K	Buy	19,542 +14,068	+257%	+$733K	0.04%	491
2021 Q2	$285K	Sell	5,474 -7,152	-57%	-$336K	0.01%	753
2021 Q1	$577K	Buy	12,626 +6,270	+99%	+$306K	0.03%	465
2020 Q4	$292K	Buy	+6,356	New	+$274K	0.02%	497

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Flow Traders U.S.'s IDNA Position: Q2 2026 in Review

Flow Traders U.S. opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2026: 12,693 shares worth $428K. The stake represents 0.02% of the portfolio and ranks #678 among its holdings. This is a return to the name: Flow Traders U.S. previously reported a position in IDNA as recently as Q4 2025.

Flow Traders U.S. first reported a position in IDNA in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.13M in Q4 2024. 65 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Flow Traders U.S. held 12,693 shares of iShares Genomics Immunology and Healthcare ETF worth $428K as of Q2 2026.
iShares Genomics Immunology and Healthcare ETF was a new Flow Traders U.S. position in Q2 2026.
iShares Genomics Immunology and Healthcare ETF made up 0.02% of Flow Traders U.S.'s portfolio in Q2 2026, its #678 holding.
Flow Traders U.S. first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and has held it in 11 quarters since.
Flow Traders U.S.'s iShares Genomics Immunology and Healthcare ETF position peaked at $2.13M in Q4 2024.
65 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.